Royal Bank of Canada »

Celldex Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $264k 7.8k 34.08
2024-06-30 $241k 6.6k 36.36
2024-03-31 $78k 1.9k 41.75
2023-12-31 $595k 15k 39.68
2023-09-30 $211k 7.8k 27.14
2023-06-30 $170k 5.0k 33.87
2022-12-31 $226k 5.4k 41.92
2022-09-30 $17k 593 29.41
2021-06-30 $90k 2.7k 33.53
2020-12-31 $4.0k 245 16.33
2020-09-30 $0 13 0.00
2020-06-30 $3.2k 272 11.58
2020-03-31 $2.0k 1.4k 1.41
2019-12-31 $1.0k 485 2.12
2019-09-30 $1.0k 569 1.80
2019-03-31 $0 13 0.00